9 July 2026 ANCA-associated vasculitis FDA Pharmaceuticals Avacopan trial retracted as regulators diverge
9 July 2026 ANCA-associated vasculitis Pharmaceuticals CSL issues open letter as EU moves to revoke avacopan approval
30 October 2025 SPONSORED ANCA-associated vasculitis Pharmaceuticals Transforming AAV treatment: One year in